Optimization of N‐Piperidinyl‐Benzimidazolone Derivatives as Potent and Selective Inhibitors of 8‐Oxo‐Guanine DNA Glycosylase 1. (13th October 2022)
- Record Type:
- Journal Article
- Title:
- Optimization of N‐Piperidinyl‐Benzimidazolone Derivatives as Potent and Selective Inhibitors of 8‐Oxo‐Guanine DNA Glycosylase 1. (13th October 2022)
- Main Title:
- Optimization of N‐Piperidinyl‐Benzimidazolone Derivatives as Potent and Selective Inhibitors of 8‐Oxo‐Guanine DNA Glycosylase 1
- Authors:
- Wallner, Olov
Cázares‐Körner, Armando
Scaletti, Emma Rose
Masuyer, Geoffrey
Bekkhus, Tove
Visnes, Torkild
Mamonov, Kirill
Ortis, Florian
Lundbäck, Thomas
Volkova, Maria
Koolmeister, Tobias
Wiita, Elisée
Loseva, Olga
Pandey, Monica
Homan, Evert
Benítez‐Buelga, Carlos
Davies, Jonathan
Scobie, Martin
Warpman Berglund, Ulrika
Kalderén, Christina
Stenmark, Pål
Helleday, Thomas
Michel, Maurice - Abstract:
- Abstract: 8‐oxo Guanine DNA Glycosylase 1 is the initiating enzyme within base excision repair and removes oxidized guanines from damaged DNA. Since unrepaired 8‐oxoG could lead to G : C→T : A transversion, base removal is of utmost importance for cells to ensure genomic integrity. For cells with elevated levels of reactive oxygen species this dependency is further increased. In the past we and others have validated OGG1 as a target for inhibitors to treat cancer and inflammation. Here, we present the optimization campaign that led to the broadly used tool compound TH5487. Based on results from a small molecule screening campaign, we performed hit to lead expansion and arrived at potent and selective substituted N ‐piperidinyl‐benzimidazolones. Using X‐ray crystallography data, we describe the surprising binding mode of the most potent member of the class, TH8535. Here, the N ‐Piperidinyl‐linker adopts a chair instead of a boat conformation which was found for weaker analogues. We further demonstrate cellular target engagement and efficacy of TH8535 against a number of cancer cell lines. Abstract : 8‐Oxoguanine DNA glycosylase 1 (OGG1) excises oxidized guanine from DNA. Besides this role in genomic integrity maintenance, the enzyme has been implicated in transcription processes and as a target to suppress inflammation. Pharmacological modulation of OGG1 has greatly contributed to understand underlying functions of bas excision repair. Here, we report on the discovery andAbstract: 8‐oxo Guanine DNA Glycosylase 1 is the initiating enzyme within base excision repair and removes oxidized guanines from damaged DNA. Since unrepaired 8‐oxoG could lead to G : C→T : A transversion, base removal is of utmost importance for cells to ensure genomic integrity. For cells with elevated levels of reactive oxygen species this dependency is further increased. In the past we and others have validated OGG1 as a target for inhibitors to treat cancer and inflammation. Here, we present the optimization campaign that led to the broadly used tool compound TH5487. Based on results from a small molecule screening campaign, we performed hit to lead expansion and arrived at potent and selective substituted N ‐piperidinyl‐benzimidazolones. Using X‐ray crystallography data, we describe the surprising binding mode of the most potent member of the class, TH8535. Here, the N ‐Piperidinyl‐linker adopts a chair instead of a boat conformation which was found for weaker analogues. We further demonstrate cellular target engagement and efficacy of TH8535 against a number of cancer cell lines. Abstract : 8‐Oxoguanine DNA glycosylase 1 (OGG1) excises oxidized guanine from DNA. Besides this role in genomic integrity maintenance, the enzyme has been implicated in transcription processes and as a target to suppress inflammation. Pharmacological modulation of OGG1 has greatly contributed to understand underlying functions of bas excision repair. Here, we report on the discovery and chemical optimization that led to widely used tool compound TH5487. … (more)
- Is Part Of:
- ChemMedChem. Volume 18:Number 1(2023)
- Journal:
- ChemMedChem
- Issue:
- Volume 18:Number 1(2023)
- Issue Display:
- Volume 18, Issue 1 (2023)
- Year:
- 2023
- Volume:
- 18
- Issue:
- 1
- Issue Sort Value:
- 2023-0018-0001-0000
- Page Start:
- n/a
- Page End:
- n/a
- Publication Date:
- 2022-10-13
- Subjects:
- Base excision repair -- 8-oxo guanine DNA glycoslyase 1 -- Inhibitors -- OGG1 -- TH5487
Pharmaceutical chemistry -- Periodicals
615.19005 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1860-7187 ↗
http://www3.interscience.wiley.com/cgi-bin/jhome/110485305 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/cmdc.202200310 ↗
- Languages:
- English
- ISSNs:
- 1860-7179
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3172.254000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 25169.xml